[Elsevier] T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1℅4-1BB bispecific antibody

abix26 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-04 16:43
Reward30points

journalㄩImmunity

AuthorsㄩCarlos Luri-Rey; Inmaculada Rodr赤guez; Saioa Arrieta-Aranzueque; David Ruiz Guillam車n; Enric Vercher; Nekane Soria; Paula Molero-Glez; Raquel Cuesta; Gabriel Gomis; Arantza Azpilikueta; Elixabet Bolaos; Almudena Manzanal; Saray Garasa; Tsuneyasu Kaisho; Raluca Alexandru; Paulo P谷rez Dom赤nguez; Alfonso Calvo; Francisco Exposito; Ignacio Heras-Murillo; David Sancho; Michela Capello; Nora Pencheva; Pedro Berraondo; Carlos de Andrea; Maria Jure-Kunkel; lvaro Teijeira; Ignacio Melero

Published dateㄩ2026-10-

DOIㄩ10.1016/j.immuni.2026.10.003

PDF linkㄩhttps://www.sciencedirect.com/sc ... 074761326004280/pdf

Article linkㄩhttps://doi.org/10.1016/j.immuni.2026.10.003

Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    3370


Return to the list